statistiche ricercatore

Continente	#
NA - Nord America	936
EU - Europa	697
AS - Asia	443
SA - Sud America	117
AF - Africa	18
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.212

Nazione	#
US - Stati Uniti d'America	925
RU - Federazione Russa	183
CN - Cina	132
GB - Regno Unito	128
SG - Singapore	110
IE - Irlanda	109
BR - Brasile	93
VN - Vietnam	83
IT - Italia	76
SE - Svezia	45
FR - Francia	32
DE - Germania	30
HK - Hong Kong	30
UA - Ucraina	30
FI - Finlandia	22
IN - India	16
KR - Corea	15
ZA - Sudafrica	13
BE - Belgio	11
AR - Argentina	8
TR - Turchia	8
CA - Canada	7
ID - Indonesia	7
NL - Olanda	6
AT - Austria	5
BD - Bangladesh	5
JP - Giappone	5
SA - Arabia Saudita	5
AE - Emirati Arabi Uniti	4
AZ - Azerbaigian	4
CH - Svizzera	4
ES - Italia	4
PK - Pakistan	4
PY - Paraguay	4
CZ - Repubblica Ceca	3
EC - Ecuador	3
IQ - Iraq	3
KZ - Kazakistan	3
MX - Messico	3
PL - Polonia	3
UY - Uruguay	3
VE - Venezuela	3
CO - Colombia	2
EG - Egitto	2
NG - Nigeria	2
UZ - Uzbekistan	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
BA - Bosnia-Erzegovina	1
CR - Costa Rica	1
GR - Grecia	1
HR - Croazia	1
IL - Israele	1
IR - Iran	1
LB - Libano	1
LT - Lituania	1
MA - Marocco	1
MY - Malesia	1
NO - Norvegia	1
NP - Nepal	1
PE - Perù	1
TH - Thailandia	1
TW - Taiwan	1
Totale	2.212

Nome	#
Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3σ protein-protein interactions	289
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections	273
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs	263
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform	263
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity	261
Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors	225
Development of flavonol and flavanone derivatives as anti-trypanosomatidic drugs	213
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases	165
Multitarget, selective compound design yields potent inhibitors of a Kinetoplastid Pteridine Reductase 1	155
Crystal structure of the ternary complex of Leishmania major pteridine reductase 1 with the cofactor NADP+/NADPH and the substrate folic acid	153
Totale	2.260

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	63	0	0	0	0	0	0	0	0	0	20	9	34
2021/2022	127	4	19	9	14	11	4	6	6	8	10	11	25
2022/2023	148	8	11	23	11	17	34	5	12	17	2	6	2
2023/2024	192	7	7	16	13	9	52	60	1	3	7	0	17
2024/2025	306	10	13	29	14	36	27	9	10	33	12	35	78
2025/2026	831	60	129	119	151	165	22	75	20	36	54	0	0
Totale													2.260